Alessandro Russo
机构: Medical Oncology Unit AO Papardo & Department of Human Pathology, University of Messina
每年引用次数
引用次数
引用: 3,549
H-指数: 32
I10-指数 : 72
出版物: 166
Challenges and perspectives in the multidisciplinary management of well-differentiated lung neuroendocrine tumours: a case report
Tindara Franchina , Alessandro Russo , Vincenzo Adamo , Giuseppina Rr Ricciardi
Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche 105 ( 1) 3
2017
Challenges with anti-PD1 agents in brain metastases management of NSCLC patients: a case report
Tindara Franchina , Alessandro Russo , Giuseppina Rosaria Rita Ricciardi , Vincenzo Adamo
Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche 106 ( 1) 6
2018
When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review.
July Rodríguez , Jenny Avila , Christian Rolfo , Alejandro Ruíz-Patiño
Oncology and Therapy 9 ( 1) 89 -110
18
2021
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Marcello Tiseo , David J. Pinato , Giulio Metro , Sergio Bracarda
European Journal of Cancer 148 24 -35
1
2021
Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021.
Umberto Malapelle , Antonino Iaccarino , Luca Quagliata , Christian Rolfo
Critical Reviews in Oncology Hematology 161 103311
19
2021
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.
David J Pinato , David J Pinato , Antonino Grassadonia , Giulio Metro
Journal for ImmunoTherapy of Cancer 9 ( 4)
2
2021
Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective.
Umberto Malapelle , Christian Rolfo , Valeria Denninghoff , Alessandro Russo
Cancers 13 ( 7) 1723
2021
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy
Marcello Tiseo , David J. Pinato , David J. Pinato , Giulio Metro
European Journal of Cancer 150 224 -231
2021
Progression patterns after EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutated (EGFR-mut+) non small cell lung cancers (NSCLCs): Correlations with clinical oucomes.
Alessandro Russo , Valeria Smiroldo , Fabio Raiti , Tindara Franchina
Journal of Clinical Oncology 34
2016
Association between baseline absolute neutrophil count (ANC), derived neutrophil-to-lymphocyte ratio (dNLR), and platelet-to-lymphocyte ratio (PLR) and response to nivolumab (Nivo) in non-small cell lung cancer (NSCLC): A preliminary analysis.
Alessandro Russo , Antonino Scimone , Maria Picciotto , Giuseppe Toscano
Journal of Clinical Oncology 35
6
2017
Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy.
Christian Rolfo , Alessandro Russo , Diego Miguel‐Pérez
Cancer 126 ( 18) 4089 -4091
1
2020
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
Alessandro Russo , Tindara Franchina , Giuseppina Rosaria Rita Ricciardi , Antonio Picone
Oncotarget 6 ( 29) 26814 -26825
174
2015
Is There Room for Personalized Medicine in Small-Cell Lung Cancer (SCLC)? Remarkable Activity of Pazopanib in Refractory FGFR1-Amplified ED-SCLC
Alessandro Russo , David Arias Ron , Marika Rasschaert , Hans Prenen
JCO Precision Oncology ( 3) 1 -8
2
2019
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases.
Vincenzo Adamo , Giuseppina Rosaria Rita Ricciardi , Alessandro Russo , Tindara Franchina
OncoTargets and Therapy 8 289 -294
6
2015
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review
Giuseppina Rosaria Rita Ricciardi , Alessandro Russo , Tindara Franchina , Silvia Schifano
BMC Cancer 18 ( 1) 97 -97
13
2018
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance
Alessandro Russo , Tindara Franchina , Giuseppina Rosaria Rita Ricciardi , Giuseppa Ferraro
Expert Review of Anticancer Therapy 16 ( 6) 615 -623
12
2016
Liquid biopsy tracking of lung tumor evolutions over time.
Alessandro Russo , Diego De Miguel Perez , Muthukumar Gunasekaran , Katherine Scilla
Expert Review of Molecular Diagnostics 19 ( 12) 1099 -1108
17
2019
HER2 Mutations in Non–Small Cell Lung Cancer: A Herculean Effort to Hit the Target
Christian Rolfo , Alessandro Russo
Cancer Discovery 10 ( 5) 643 -645
2
2020
Liquid biopsy for early stage lung cancer moves ever closer
Christian Rolfo , Alessandro Russo
Nature Reviews Clinical Oncology 17 ( 9) 523 -524
4
2020
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer
Alessandro Russo , Tindara Franchina , Giuseppina Rosaria Rita Ricciardi , Caterina Fanizza
Oncotarget 8 ( 5) 8717 -8725
6
2017